Today certainly appears to be shaping up as a pause to the recent uptrend in the markets. We have more big earnings after the bell, so traders need to tread carefully here. Let's take a look at some names that are worth tracking.


Earnings Winners: Pfizer ( PFE), SunTrust Banks ( STI), Apple ( AAPL), Starbucks ( SBUX), Illumina ( ILMN), C.H. Robinson Worldwide ( CHRW) and homebuilder NVR, Inc ( NVR) are all trading higher.

Onyx Pharmaceuticals ( ONXX): Shares are surging on positive breast cancer drug study data.

Other Notable Winners: FedEx Corp ( FDX), KB Home ( KBH), and Wynn Resorts ( WYNN) are gaining.


Earnings Losers: St. Jude Medical ( STJ), Genzyme Corp ( GENZ), Aaron's Inc. ( AAN), Wells Fargo ( WFC), Allegheny Technologies ( ATI), Whirlpool ( WHR) and Bank of NY Mellon ( BK) are some of the biggest losers.

Other Notable Pullbacks: First Solar ( FSLR), Fuqui International ( FUQI) and Baidu ( BIDU).

What's the Trade?

It certainly feels like a consolidation day may be in the cards for today's action. Oil ( USO) is lower in the early going, but Gold ( GLD) is digging in with some gains so far. Treasuries ( TLT) are down a bit as bond traders try to parse through the latest economic data which showed recent home prices with a slight uptick. Inflation watchers are looking for any signs that the massive amount of money supply may be beginning to have an effect.

As for some of the ideas I mentioned this morning, there has not been a clear entry point yet for a short position in Agnico-Eagle Mines ( AEM) or U.S. Steel ( X).

I am still monitoring those two plays as well as Baidu ( BIDU). That red-hot stock, which was upgraded this morning, has not responded well so far today. This could be a signal that a pullback may be in the works for momentum plays and the market in general, so I'll be watching the market closely.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux